Neoplasms

Urinary Tract, Sexual Organs, and Pregnancy Conditions

All Conditions

Prostatic Neoplasms

Genital Neoplasms, Male

Urogenital Neoplasms

Genital Diseases

Genital Diseases, Male

Urogenital Diseases

Prostatic Diseases

Male Urogenital Diseases

Mark L Perman, MD

Debra E Freeman, MD

Mike Rickman

Fred Dumas, MD

Roger Ove, MD, PhD

Monica Baker, ROCC

Lauren D Stegman, MD

Bonnie Harkins, RN, OCN, CCRP

Brent Kane, MD

Amanda Schwer, MD

Patrick Linson, MD

Paul Kim, MD

Cami Bremer

Jodi Harr

Anuj Peddada, M.D.

Toni Cody

Kelley C Simpson, MD

Gregg Dickerson, MD

Greg Dickerson, MD

Linda Winger

Sean P Collins, MD, PhD

Gail Suarez

James Schwade, MD

Debra Freeman, MD

S Sundararaman, MD

Srinath Sundararaman, MD

Mark Perman, MD

Beth Kost

Mark McLaughlin, MD

Anne Dunlap

Andy Su, MD

Linda Green, BS,RN

Arica Hirsch, MD

Anne Wray

Alan Beckman, MD

Lee McNeely, MD

Kerstin Leigland, BA, CCRC

Kelly Underhill, MD

Holly Frydenlund

Jeffery Stephenson, MD

Kevin Yiee, MD

Isis Amoy

Dan L Curtis, MD

James Gann

Jonathan Tay, MD

Stephanie Ullo

Adnan Danish, MD

Michelle Karedes

Rashid Haq, MD

Kathy Corbett

Mandy Hess

Edward Hughes, MD

Candida Barlow, MSN, CTN, RN

Frederick Willison, MD

Katherine Wood

Diane Heaton, MD

Matt Weaver, BC, CCRC

Wendy Wheaton

Michael S Payne, MD

Cindy Winker

Michael Good, RN,BSN,MAR

John Lamond, MD

Sheila C Baucum, RN, APN-AOCNS

James R Gray, MD

Melissa Cronn

Paiman Ghafoori, MD

Timothy D Nichols, MD

Gail Wade

Matthew Cavey, MD

Catalina Gutierrez

Cheryl Fullmer

L. Steven Carpenter, MD

Melissa Blough, PhD

Joaquin G Mira, MD

Jeanetta Patterson, RN, BA OCN

Jeffery Gilmore, MD

Stephanie VanBebber

Samir Kanani, MD

Karie-Lynn Kelly, MD

Mathew

Karie- Lynn Kelly, MD

Kara Makin-Bond

Michael Myers, MD

Beverly Smith, BSN, OCN

Sanjeev Sharma, MD

Mark L. Perman, MD

To address pertinent questions regarding the utilization of stereotactic Body Radiotherapy (SBRT) to treat prostate cancer. The Florida Robotic Radiosurgery Association (FRRA) launched the first registry for prostate cancer patients treated with SBRT. The registry is designed to track surrogate treatment endpoints including prostate specific antigen (PSA), international prostate symptom score (IPSS),sexual health in men (SHIM), and visual analogue scale (VAS) scores, in addition to physical and survival data. Utilizing an independent vendor (Advertek, Inc.) experienced with the design and implementation of similar electronic registries, FRRA developed a data collection tool that staff members with a basic medical background can use to register and upload pertinent patient data, requiring no more than 20 to 30 minutes per patient. Participating patients will be monitored in follow-up for three years, with analysis and publication of the results semi-annually.

To address pertinent questions regarding the utilization of radiosurgery (SBRT) to treat prostate cancer. The Florida Robotic Radiosurgery Association (FRRA) launched the first registry for prostate cancer patients treated with SBRT.

The registry is designed to track surrogate treatment endpoints including PSA, IPSS, SHIM, QOL, Karnofsky Performance Status, VAS scores, urine and bowel health, in addition to physical and survival data. Utilizing an independent vendor (Advertek, Inc.) experienced with the design and implementation of similar electronic registries.

FRRA developed a data collection tool that staff members with a basic medical background can use to register and upload pertinent patient data requiring no more than 20 to 30 minutes per patient. Participating patients will be monitored in follow-up for three years, with analysis and publication of the results semi-annually.

Multi-Institutional Registry for Prostate Cancer Radiosurgery

Multi-Institutional Registry for Prostate Cancer Radiosurgery. An IRB Approved Observational Trial

Measurement of surrogate outcomes including IPSS and SHIM scores

urinary and rectal complications as well as sexual health

RPCR, Inc.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Multi-Institutional Registry for Prostate Cancer Radiosurgery	NCT01226004	Prostate Cancer... Prostate Cancer...		18 Years - 90 Years	RPCR, Inc.
Multi-Institutional Registry for Prostate Cancer Radiosurgery	NCT01226004	Prostate Cancer... Prostate Cancer...		18 Years - 90 Years	RPCR, Inc.

Spots Global Cancer Trial Database for prostate cancer intermediate risk treated by radiosurgery